ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hepatitis A and B Vaccination Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-31M13002
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Hepatitis A and B Vaccination Market Research Report 2023
BUY CHAPTERS

Global Hepatitis A and B Vaccination Market Research Report 2025

Code: QYRE-Auto-31M13002
Report
January 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
Imbcams
Convac
NCPC
Bio Kangtai
Dynavax
Hissen
LG Life Sciences
Serum Institute

Hepatitis A and B Vaccination Market Size

The global market for Hepatitis A and B Vaccination was valued at US$ 1860 million in the year 2024 and is projected to reach a revised size of US$ 2104 million by 2031, growing at a CAGR of 1.8% during the forecast period.

Hepatitis A and B Vaccination Market

Hepatitis A and B Vaccination Market

The hepatitis A and hepatitis B vaccines can be given separately or as a combination vaccine. All the shots in the series are needed for long-term protection. The full series of the hepatitis A and hepatitis B vaccines require 2-3 shots, depending on the type of vaccine.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hepatitis A and B Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis A and B Vaccination.
The Hepatitis A and B Vaccination market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hepatitis A and B Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis A and B Vaccination manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Hepatitis A and B Vaccination Market Report

Report Metric Details
Report Name Hepatitis A and B Vaccination Market
Accounted market size in year US$ 1860 million
Forecasted market size in 2031 US$ 2104 million
CAGR 1.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Government Institution
  • Private Sector
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS, Convac, NCPC, Bio Kangtai, Dynavax, Hissen, LG Life Sciences, Serum Institute
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Hepatitis A and B Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Hepatitis A and B Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Hepatitis A and B Vaccination Market growing?

Ans: The Hepatitis A and B Vaccination Market witnessing a CAGR of 1.8% during the forecast period 2025-2031.

What is the Hepatitis A and B Vaccination Market size in 2031?

Ans: The Hepatitis A and B Vaccination Market size in 2031 will be US$ 2104 million.

Who are the main players in the Hepatitis A and B Vaccination Market report?

Ans: The main players in the Hepatitis A and B Vaccination Market are GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS, Convac, NCPC, Bio Kangtai, Dynavax, Hissen, LG Life Sciences, Serum Institute

What are the Application segmentation covered in the Hepatitis A and B Vaccination Market report?

Ans: The Applications covered in the Hepatitis A and B Vaccination Market report are Government Institution, Private Sector, Other

What are the Type segmentation covered in the Hepatitis A and B Vaccination Market report?

Ans: The Types covered in the Hepatitis A and B Vaccination Market report are Hepatitis A Vaccination, Hepatitis B Vaccination

Recommended Reports

Human Vaccines

Hepatitis and Liver

Vaccine Technology

1 Hepatitis A and B Vaccination Market Overview
1.1 Product Definition
1.2 Hepatitis A and B Vaccination by Type
1.2.1 Global Hepatitis A and B Vaccination Market Value Comparison by Type (2024 VS 2031)
1.2.2 Hepatitis A Vaccination
1.2.3 Hepatitis B Vaccination
1.3 Hepatitis A and B Vaccination by Application
1.3.1 Global Hepatitis A and B Vaccination Market Value by Application (2024 VS 2031)
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Global Hepatitis A and B Vaccination Market Size Estimates and Forecasts
1.4.1 Global Hepatitis A and B Vaccination Revenue 2020-2031
1.4.2 Global Hepatitis A and B Vaccination Sales 2020-2031
1.4.3 Global Hepatitis A and B Vaccination Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Hepatitis A and B Vaccination Market Competition by Manufacturers
2.1 Global Hepatitis A and B Vaccination Sales Market Share by Manufacturers (2020-2025)
2.2 Global Hepatitis A and B Vaccination Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Hepatitis A and B Vaccination Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Hepatitis A and B Vaccination, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hepatitis A and B Vaccination, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hepatitis A and B Vaccination, Product Type & Application
2.7 Global Key Manufacturers of Hepatitis A and B Vaccination, Date of Enter into This Industry
2.8 Global Hepatitis A and B Vaccination Market Competitive Situation and Trends
2.8.1 Global Hepatitis A and B Vaccination Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Hepatitis A and B Vaccination Players Market Share by Revenue
2.8.3 Global Hepatitis A and B Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hepatitis A and B Vaccination Market Scenario by Region
3.1 Global Hepatitis A and B Vaccination Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Hepatitis A and B Vaccination Sales by Region: 2020-2031
3.2.1 Global Hepatitis A and B Vaccination Sales by Region: 2020-2025
3.2.2 Global Hepatitis A and B Vaccination Sales by Region: 2026-2031
3.3 Global Hepatitis A and B Vaccination Revenue by Region: 2020-2031
3.3.1 Global Hepatitis A and B Vaccination Revenue by Region: 2020-2025
3.3.2 Global Hepatitis A and B Vaccination Revenue by Region: 2026-2031
3.4 North America Hepatitis A and B Vaccination Market Facts & Figures by Country
3.4.1 North America Hepatitis A and B Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Hepatitis A and B Vaccination Sales by Country (2020-2031)
3.4.3 North America Hepatitis A and B Vaccination Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hepatitis A and B Vaccination Market Facts & Figures by Country
3.5.1 Europe Hepatitis A and B Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Hepatitis A and B Vaccination Sales by Country (2020-2031)
3.5.3 Europe Hepatitis A and B Vaccination Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hepatitis A and B Vaccination Market Facts & Figures by Region
3.6.1 Asia Pacific Hepatitis A and B Vaccination Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Hepatitis A and B Vaccination Sales by Region (2020-2031)
3.6.3 Asia Pacific Hepatitis A and B Vaccination Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hepatitis A and B Vaccination Market Facts & Figures by Country
3.7.1 Latin America Hepatitis A and B Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Hepatitis A and B Vaccination Sales by Country (2020-2031)
3.7.3 Latin America Hepatitis A and B Vaccination Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hepatitis A and B Vaccination Market Facts & Figures by Country
3.8.1 Middle East and Africa Hepatitis A and B Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Hepatitis A and B Vaccination Sales by Country (2020-2031)
3.8.3 Middle East and Africa Hepatitis A and B Vaccination Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hepatitis A and B Vaccination Sales by Type (2020-2031)
4.1.1 Global Hepatitis A and B Vaccination Sales by Type (2020-2025)
4.1.2 Global Hepatitis A and B Vaccination Sales by Type (2026-2031)
4.1.3 Global Hepatitis A and B Vaccination Sales Market Share by Type (2020-2031)
4.2 Global Hepatitis A and B Vaccination Revenue by Type (2020-2031)
4.2.1 Global Hepatitis A and B Vaccination Revenue by Type (2020-2025)
4.2.2 Global Hepatitis A and B Vaccination Revenue by Type (2026-2031)
4.2.3 Global Hepatitis A and B Vaccination Revenue Market Share by Type (2020-2031)
4.3 Global Hepatitis A and B Vaccination Price by Type (2020-2031)
5 Segment by Application
5.1 Global Hepatitis A and B Vaccination Sales by Application (2020-2031)
5.1.1 Global Hepatitis A and B Vaccination Sales by Application (2020-2025)
5.1.2 Global Hepatitis A and B Vaccination Sales by Application (2026-2031)
5.1.3 Global Hepatitis A and B Vaccination Sales Market Share by Application (2020-2031)
5.2 Global Hepatitis A and B Vaccination Revenue by Application (2020-2031)
5.2.1 Global Hepatitis A and B Vaccination Revenue by Application (2020-2025)
5.2.2 Global Hepatitis A and B Vaccination Revenue by Application (2026-2031)
5.2.3 Global Hepatitis A and B Vaccination Revenue Market Share by Application (2020-2031)
5.3 Global Hepatitis A and B Vaccination Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Company Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Hepatitis A and B Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GSK Hepatitis A and B Vaccination Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Hepatitis A and B Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck Hepatitis A and B Vaccination Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Hepatitis A and B Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi Hepatitis A and B Vaccination Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Sinovac
6.4.1 Sinovac Company Information
6.4.2 Sinovac Description and Business Overview
6.4.3 Sinovac Hepatitis A and B Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sinovac Hepatitis A and B Vaccination Product Portfolio
6.4.5 Sinovac Recent Developments/Updates
6.5 Zhejiang Pukang
6.5.1 Zhejiang Pukang Company Information
6.5.2 Zhejiang Pukang Description and Business Overview
6.5.3 Zhejiang Pukang Hepatitis A and B Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Zhejiang Pukang Hepatitis A and B Vaccination Product Portfolio
6.5.5 Zhejiang Pukang Recent Developments/Updates
6.6 Changchun Institute of Biological
6.6.1 Changchun Institute of Biological Company Information
6.6.2 Changchun Institute of Biological Description and Business Overview
6.6.3 Changchun Institute of Biological Hepatitis A and B Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Changchun Institute of Biological Hepatitis A and B Vaccination Product Portfolio
6.6.5 Changchun Institute of Biological Recent Developments/Updates
6.7 KM Biologics
6.7.1 KM Biologics Company Information
6.7.2 KM Biologics Description and Business Overview
6.7.3 KM Biologics Hepatitis A and B Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.7.4 KM Biologics Hepatitis A and B Vaccination Product Portfolio
6.7.5 KM Biologics Recent Developments/Updates
6.8 IMBCAMS
6.8.1 IMBCAMS Company Information
6.8.2 IMBCAMS Description and Business Overview
6.8.3 IMBCAMS Hepatitis A and B Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.8.4 IMBCAMS Hepatitis A and B Vaccination Product Portfolio
6.8.5 IMBCAMS Recent Developments/Updates
6.9 Convac
6.9.1 Convac Company Information
6.9.2 Convac Description and Business Overview
6.9.3 Convac Hepatitis A and B Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Convac Hepatitis A and B Vaccination Product Portfolio
6.9.5 Convac Recent Developments/Updates
6.10 NCPC
6.10.1 NCPC Company Information
6.10.2 NCPC Description and Business Overview
6.10.3 NCPC Hepatitis A and B Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.10.4 NCPC Hepatitis A and B Vaccination Product Portfolio
6.10.5 NCPC Recent Developments/Updates
6.11 Bio Kangtai
6.11.1 Bio Kangtai Company Information
6.11.2 Bio Kangtai Description and Business Overview
6.11.3 Bio Kangtai Hepatitis A and B Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Bio Kangtai Hepatitis A and B Vaccination Product Portfolio
6.11.5 Bio Kangtai Recent Developments/Updates
6.12 Dynavax
6.12.1 Dynavax Company Information
6.12.2 Dynavax Description and Business Overview
6.12.3 Dynavax Hepatitis A and B Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Dynavax Hepatitis A and B Vaccination Product Portfolio
6.12.5 Dynavax Recent Developments/Updates
6.13 Hissen
6.13.1 Hissen Company Information
6.13.2 Hissen Description and Business Overview
6.13.3 Hissen Hepatitis A and B Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Hissen Hepatitis A and B Vaccination Product Portfolio
6.13.5 Hissen Recent Developments/Updates
6.14 LG Life Sciences
6.14.1 LG Life Sciences Company Information
6.14.2 LG Life Sciences Description and Business Overview
6.14.3 LG Life Sciences Hepatitis A and B Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.14.4 LG Life Sciences Hepatitis A and B Vaccination Product Portfolio
6.14.5 LG Life Sciences Recent Developments/Updates
6.15 Serum Institute
6.15.1 Serum Institute Company Information
6.15.2 Serum Institute Description and Business Overview
6.15.3 Serum Institute Hepatitis A and B Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Serum Institute Hepatitis A and B Vaccination Product Portfolio
6.15.5 Serum Institute Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hepatitis A and B Vaccination Industry Chain Analysis
7.2 Hepatitis A and B Vaccination Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hepatitis A and B Vaccination Production Mode & Process Analysis
7.4 Hepatitis A and B Vaccination Sales and Marketing
7.4.1 Hepatitis A and B Vaccination Sales Channels
7.4.2 Hepatitis A and B Vaccination Distributors
7.5 Hepatitis A and B Vaccination Customer Analysis
8 Hepatitis A and B Vaccination Market Dynamics
8.1 Hepatitis A and B Vaccination Industry Trends
8.2 Hepatitis A and B Vaccination Market Drivers
8.3 Hepatitis A and B Vaccination Market Challenges
8.4 Hepatitis A and B Vaccination Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
Imbcams
Convac
NCPC
Bio Kangtai
Dynavax
Hissen
LG Life Sciences
Serum Institute
List of Tables
 Table 1. Global Hepatitis A and B Vaccination Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Hepatitis A and B Vaccination Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Hepatitis A and B Vaccination Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Hepatitis A and B Vaccination Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Hepatitis A and B Vaccination Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Hepatitis A and B Vaccination Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Hepatitis A and B Vaccination Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Hepatitis A and B Vaccination Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Hepatitis A and B Vaccination, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Hepatitis A and B Vaccination, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Hepatitis A and B Vaccination, Product Type & Application
 Table 12. Global Key Manufacturers of Hepatitis A and B Vaccination, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Hepatitis A and B Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis A and B Vaccination as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Hepatitis A and B Vaccination Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Hepatitis A and B Vaccination Sales by Region (2020-2025) & (K Units)
 Table 18. Global Hepatitis A and B Vaccination Sales Market Share by Region (2020-2025)
 Table 19. Global Hepatitis A and B Vaccination Sales by Region (2026-2031) & (K Units)
 Table 20. Global Hepatitis A and B Vaccination Sales Market Share by Region (2026-2031)
 Table 21. Global Hepatitis A and B Vaccination Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Hepatitis A and B Vaccination Revenue Market Share by Region (2020-2025)
 Table 23. Global Hepatitis A and B Vaccination Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Hepatitis A and B Vaccination Revenue Market Share by Region (2026-2031)
 Table 25. North America Hepatitis A and B Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Hepatitis A and B Vaccination Sales by Country (2020-2025) & (K Units)
 Table 27. North America Hepatitis A and B Vaccination Sales by Country (2026-2031) & (K Units)
 Table 28. North America Hepatitis A and B Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Hepatitis A and B Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Hepatitis A and B Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Hepatitis A and B Vaccination Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Hepatitis A and B Vaccination Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Hepatitis A and B Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Hepatitis A and B Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Hepatitis A and B Vaccination Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Hepatitis A and B Vaccination Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Hepatitis A and B Vaccination Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Hepatitis A and B Vaccination Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Hepatitis A and B Vaccination Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Hepatitis A and B Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Hepatitis A and B Vaccination Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Hepatitis A and B Vaccination Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Hepatitis A and B Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Hepatitis A and B Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Hepatitis A and B Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Hepatitis A and B Vaccination Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Hepatitis A and B Vaccination Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Hepatitis A and B Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Hepatitis A and B Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Hepatitis A and B Vaccination Sales (K Units) by Type (2020-2025)
 Table 51. Global Hepatitis A and B Vaccination Sales (K Units) by Type (2026-2031)
 Table 52. Global Hepatitis A and B Vaccination Sales Market Share by Type (2020-2025)
 Table 53. Global Hepatitis A and B Vaccination Sales Market Share by Type (2026-2031)
 Table 54. Global Hepatitis A and B Vaccination Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Hepatitis A and B Vaccination Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Hepatitis A and B Vaccination Revenue Market Share by Type (2020-2025)
 Table 57. Global Hepatitis A and B Vaccination Revenue Market Share by Type (2026-2031)
 Table 58. Global Hepatitis A and B Vaccination Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Hepatitis A and B Vaccination Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Hepatitis A and B Vaccination Sales (K Units) by Application (2020-2025)
 Table 61. Global Hepatitis A and B Vaccination Sales (K Units) by Application (2026-2031)
 Table 62. Global Hepatitis A and B Vaccination Sales Market Share by Application (2020-2025)
 Table 63. Global Hepatitis A and B Vaccination Sales Market Share by Application (2026-2031)
 Table 64. Global Hepatitis A and B Vaccination Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Hepatitis A and B Vaccination Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Hepatitis A and B Vaccination Revenue Market Share by Application (2020-2025)
 Table 67. Global Hepatitis A and B Vaccination Revenue Market Share by Application (2026-2031)
 Table 68. Global Hepatitis A and B Vaccination Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Hepatitis A and B Vaccination Price (US$/Unit) by Application (2026-2031)
 Table 70. GSK Company Information
 Table 71. GSK Description and Business Overview
 Table 72. GSK Hepatitis A and B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. GSK Hepatitis A and B Vaccination Product
 Table 74. GSK Recent Developments/Updates
 Table 75. Merck Company Information
 Table 76. Merck Description and Business Overview
 Table 77. Merck Hepatitis A and B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Merck Hepatitis A and B Vaccination Product
 Table 79. Merck Recent Developments/Updates
 Table 80. Sanofi Company Information
 Table 81. Sanofi Description and Business Overview
 Table 82. Sanofi Hepatitis A and B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Sanofi Hepatitis A and B Vaccination Product
 Table 84. Sanofi Recent Developments/Updates
 Table 85. Sinovac Company Information
 Table 86. Sinovac Description and Business Overview
 Table 87. Sinovac Hepatitis A and B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Sinovac Hepatitis A and B Vaccination Product
 Table 89. Sinovac Recent Developments/Updates
 Table 90. Zhejiang Pukang Company Information
 Table 91. Zhejiang Pukang Description and Business Overview
 Table 92. Zhejiang Pukang Hepatitis A and B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Zhejiang Pukang Hepatitis A and B Vaccination Product
 Table 94. Zhejiang Pukang Recent Developments/Updates
 Table 95. Changchun Institute of Biological Company Information
 Table 96. Changchun Institute of Biological Description and Business Overview
 Table 97. Changchun Institute of Biological Hepatitis A and B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Changchun Institute of Biological Hepatitis A and B Vaccination Product
 Table 99. Changchun Institute of Biological Recent Developments/Updates
 Table 100. KM Biologics Company Information
 Table 101. KM Biologics Description and Business Overview
 Table 102. KM Biologics Hepatitis A and B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. KM Biologics Hepatitis A and B Vaccination Product
 Table 104. KM Biologics Recent Developments/Updates
 Table 105. IMBCAMS Company Information
 Table 106. IMBCAMS Description and Business Overview
 Table 107. IMBCAMS Hepatitis A and B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. IMBCAMS Hepatitis A and B Vaccination Product
 Table 109. IMBCAMS Recent Developments/Updates
 Table 110. Convac Company Information
 Table 111. Convac Description and Business Overview
 Table 112. Convac Hepatitis A and B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Convac Hepatitis A and B Vaccination Product
 Table 114. Convac Recent Developments/Updates
 Table 115. NCPC Company Information
 Table 116. NCPC Description and Business Overview
 Table 117. NCPC Hepatitis A and B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. NCPC Hepatitis A and B Vaccination Product
 Table 119. NCPC Recent Developments/Updates
 Table 120. Bio Kangtai Company Information
 Table 121. Bio Kangtai Description and Business Overview
 Table 122. Bio Kangtai Hepatitis A and B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Bio Kangtai Hepatitis A and B Vaccination Product
 Table 124. Bio Kangtai Recent Developments/Updates
 Table 125. Dynavax Company Information
 Table 126. Dynavax Description and Business Overview
 Table 127. Dynavax Hepatitis A and B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Dynavax Hepatitis A and B Vaccination Product
 Table 129. Dynavax Recent Developments/Updates
 Table 130. Hissen Company Information
 Table 131. Hissen Description and Business Overview
 Table 132. Hissen Hepatitis A and B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Hissen Hepatitis A and B Vaccination Product
 Table 134. Hissen Recent Developments/Updates
 Table 135. LG Life Sciences Company Information
 Table 136. LG Life Sciences Description and Business Overview
 Table 137. LG Life Sciences Hepatitis A and B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. LG Life Sciences Hepatitis A and B Vaccination Product
 Table 139. LG Life Sciences Recent Developments/Updates
 Table 140. Serum Institute Company Information
 Table 141. Serum Institute Description and Business Overview
 Table 142. Serum Institute Hepatitis A and B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Serum Institute Hepatitis A and B Vaccination Product
 Table 144. Serum Institute Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Hepatitis A and B Vaccination Distributors List
 Table 148. Hepatitis A and B Vaccination Customers List
 Table 149. Hepatitis A and B Vaccination Market Trends
 Table 150. Hepatitis A and B Vaccination Market Drivers
 Table 151. Hepatitis A and B Vaccination Market Challenges
 Table 152. Hepatitis A and B Vaccination Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hepatitis A and B Vaccination
 Figure 2. Global Hepatitis A and B Vaccination Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Hepatitis A and B Vaccination Market Share by Type: 2024 & 2031
 Figure 4. Hepatitis A Vaccination Product Picture
 Figure 5. Hepatitis B Vaccination Product Picture
 Figure 6. Global Hepatitis A and B Vaccination Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Hepatitis A and B Vaccination Market Share by Application: 2024 & 2031
 Figure 8. Government Institution
 Figure 9. Private Sector
 Figure 10. Other
 Figure 11. Global Hepatitis A and B Vaccination Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Hepatitis A and B Vaccination Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Hepatitis A and B Vaccination Sales (2020-2031) & (K Units)
 Figure 14. Global Hepatitis A and B Vaccination Average Price (US$/Unit) & (2020-2031)
 Figure 15. Hepatitis A and B Vaccination Report Years Considered
 Figure 16. Hepatitis A and B Vaccination Sales Share by Manufacturers in 2024
 Figure 17. Global Hepatitis A and B Vaccination Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Hepatitis A and B Vaccination Players: Market Share by Revenue in Hepatitis A and B Vaccination in 2024
 Figure 19. Hepatitis A and B Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Hepatitis A and B Vaccination Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Hepatitis A and B Vaccination Sales Market Share by Country (2020-2031)
 Figure 22. North America Hepatitis A and B Vaccination Revenue Market Share by Country (2020-2031)
 Figure 23. United States Hepatitis A and B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Hepatitis A and B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Hepatitis A and B Vaccination Sales Market Share by Country (2020-2031)
 Figure 26. Europe Hepatitis A and B Vaccination Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Hepatitis A and B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Hepatitis A and B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Hepatitis A and B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Hepatitis A and B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Hepatitis A and B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Hepatitis A and B Vaccination Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Hepatitis A and B Vaccination Revenue Market Share by Region (2020-2031)
 Figure 34. China Hepatitis A and B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Hepatitis A and B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Hepatitis A and B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Hepatitis A and B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Hepatitis A and B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Hepatitis A and B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Hepatitis A and B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Hepatitis A and B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Hepatitis A and B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Hepatitis A and B Vaccination Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Hepatitis A and B Vaccination Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Hepatitis A and B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Hepatitis A and B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Hepatitis A and B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Hepatitis A and B Vaccination Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Hepatitis A and B Vaccination Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Hepatitis A and B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Hepatitis A and B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Hepatitis A and B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Hepatitis A and B Vaccination by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Hepatitis A and B Vaccination by Type (2020-2031)
 Figure 55. Global Hepatitis A and B Vaccination Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Hepatitis A and B Vaccination by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Hepatitis A and B Vaccination by Application (2020-2031)
 Figure 58. Global Hepatitis A and B Vaccination Price (US$/Unit) by Application (2020-2031)
 Figure 59. Hepatitis A and B Vaccination Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Hepatitis A and B Vaccine Market Research Report 2025
Hepatitis A and B Combined Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hepatitis A Vaccination Market Research Report 2025
Global Hepatitis B Vaccination Market Research Report 2025
Hepatitis B Vaccines Market
Mono Hepatitis A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hepatitis A Vaccine Market
Mono Hepatitis B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Hepatitis B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Inactivated Hepatitis A Vaccine Market Research Report 2024
Hepatitis B Vaccine Recombinant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hepatitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Mono Hepatitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hepatitis A immunoglobulin Market Research Report 2025
Hepatitis B Virus Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Interferon Therapy of Chronic Hepatitis B Market Research Report 2024
Global HBV Rapid Test Kit Market Research Report 2025
Global Travel Vaccines Market Insights Forecast to 2030
Global Hepatitis B Treatment Market Insights Forecast to 2030
Combination Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions